Author Archive: Brian Sanchez

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Pattern Energy Group, Inc. of Class Action Lawsuit and Upcoming Deadline – PEGI



NEW YORK, Nov. 18, 2016 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Pattern Energy Group, Inc. (“Pattern” or the “Company”)












PEGI, -1.09%










and certain of its officers.   The class action, filed in United States District Court, Northern District of California, and docketed under 16-cv-06560, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Pattern securities between May 9, 2016 and November 4, 2016, both dates inclusive (the “Class Period”), seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Pattern securities during the Class Period, you have until January 10, 2017 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased. 

[Click here to join this class action]

Pattern operates as an independent power company that owns and operates power projects in the United States, Canada, and Chile. As of October 18, 2016, the Company had a portfolio of 18 wind power projects with a total owned capacity of 2,644 MW. Pattern sells electricity and renewable energy credits primarily to local utilities and local liquid independent system organizations markets.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.  Specifically, Defendants made false and/or misleading statements and/or failed to disclose that:  (i) Pattern’s operations were deficient with respect to various transaction, process level, and monitoring controls; (ii) as a result, Pattern lacked effective internal financial controls; and (iii) as a result of the foregoing, Pattern’s public statements were materially false and misleading at all relevant times.

On November 7, 2016, Pattern announced its financial and operating results for the quarter ended September 30, 2016 and disclosed a material weakness in internal controls over financial reporting.  Pattern stated that its internal controls were “not effective as of September 30, 2016, due to the aggregation of internal control deficiencies related to the implementation, design, maintenance and operating effectiveness of various transaction, process level, and monitoring controls.”  

On this news, Pattern’s share price fell $0.76, or 3.52%, to close at $20.86 on November 7, 2016.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert–pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-pattern-energy-group-inc-of-class-action-lawsuit-and-upcoming-deadline–pegi-300366157.html

SOURCE Pomerantz LLP

Copyright (C) 2016 PR Newswire. All rights reserved



















Go to Source

Pomerantz Law Firm Reminds Shareholders with Losses on their Investments Impax Laboratories Inc. of Class Action Lawsuit and Upcoming Deadline – IPXL

NEW YORK, Nov. 18, 2016 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Impax Laboratories Inc. (“Impax” or the “Company”) (NASDAQ: IPXL) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 16-cv-06557, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Impax securities between February 20, 2014 and November 2, 2016, both dates inclusive (the “Class Period”), seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Impax securities during the Class Period, you have until January 9, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

Impax, a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products. Impax Laboratories, Inc. has a strategic alliance agreement with Teva Pharmaceuticals Curacao N.V. to develop, manufacture, and distribute controlled release generic pharmaceutical products.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Impax and several of its pharmaceutical industry peers colluded to fix generic drug prices; (ii) the foregoing conduct constituted a violation of U.S. antitrust laws; (iii) consequently, Impax’s revenues during the Class Period were in part the result of illegal conduct; and (iv) as a result of the foregoing, Impax’s public statements were materially false and misleading at all relevant times.

On November 3, 2016, media outlets reported that U.S. prosecutors might file criminal charges by the end of 2016 against Impax and several other pharmaceutical companies for unlawfully colluding to fix generic drug prices.

On this news, Impax’s share price fell $4.00, or 19.51%, to close at $16.50 on November 3, 2016.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investments-impax-laboratories-inc-of-class-action-lawsuit-and-upcoming-deadline–ipxl-300366159.html

SOURCE Pomerantz LLP


Go to Source

Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline – AGN

NEW YORK, Nov. 18, 2016 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Allergan plc (“Allergan” or the “Company”) (NYSE: AGN) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-08661, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Allergan securities between February 25, 2014 and November 2, 2016, both dates inclusive (the “Class Period”), seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Allergan securities during the Class Period, you have until January 3, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

Allergan, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. The Company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015 after acquiring Allergan Inc. The Company’s common stock has traded under the ticker symbol “AGN” since June 15, 2015. Prior to June 15, 2015, the common stock of Actavis plc traded on the NYSE under the ticker symbol “ACT”.

On July 26, 2015, Allergan entered into a master purchase agreement, under which Teva Pharmaceutical Industries Ltd. agreed to acquire Actavis, the Company’s global generic pharmaceuticals business unit. On August 2, 2016, the companies announced the completion of the acquisition.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Allergan’s Actavis unit and several of its pharmaceutical industry peers colluded to fix generic drug prices; (ii) the foregoing conduct constituted a violation of federal antitrust laws; (iii) consequently, Allergan’s revenues during the Class Period were in part the result of illegal conduct; and (iv) as a result of the foregoing, Allergan’s public statements were materially false and misleading at all relevant times.

On November 3, 2016, media outlets reported that U.S. prosecutors might file criminal charges by the end of 2016 against Actavis and several other pharmaceutical companies for unlawfully colluding to fix generic drug prices.

On this news, Allergan’s share price fell $9.07, or 4.58%, to close at $188.82 on November 3, 2016.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-allergan-plc-of-class-action-lawsuit-and-upcoming-deadline–agn-300366156.html

SOURCE Pomerantz LLP


Go to Source

Sanderson Farms, Inc. : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sanderson Farms, Inc. of Class Action Lawsuit and Upcoming Deadline – SAFM

NEW YORK, NY / ACCESSWIRE / November 18, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against Sanderson Farms, Inc. (“Sanderson Farms” or the “Company”) (NASDAQ: SAFM) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-08420, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Sanderson Farms securities between December 17, 2013 and October 6, 2016 inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased Sanderson Farms securities during the Class Period, you have until December 27, 2016 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at
rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click
here to join this class action]

Sanderson Farms, an integrated poultry processing company, produces, processes, markets, and distributes fresh, frozen, and prepared chicken products in the United States. The Company sells ice pack, chill pack, bulk pack, and frozen chicken in whole, cut-up, and boneless form primarily under the Sanderson Farms brand name to retailers, distributors, and casual dining operators in the United States, as well as to customers who resell frozen chicken in the export markets. Sanderson Farms’ prepared chicken product line includes institutional and consumer packaged partially cooked or marinated chicken items for distributors and food service establishments.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Sanderson Farms systematically colluded with several of its industry peers to fix prices in the broiler-chicken market; (ii) the foregoing conduct constituted a violation of federal antitrust laws; (iii) consequently, Sanderson Farms’ revenues during the Class Period were the result of illegal conduct; and (iv) as a result of the foregoing, Sanderson Farms’ public statements were materially false and misleading at all relevant times.

On September 2, 2016, the market had its first taste of Defendants’ fraud, when Maplevale Farms, Inc. filed an antitrust class action complaint in U.S. District Court for the Northern District of Illinois (the “Maplevale Complaint”) against Sanderson Farms and several other poultry producers, including Tyson Foods, Inc. (“Tyson”), Pilgrim’s Pride Corporation, and Perdue Farms, Inc., alleging that Sanderson Farms and the other companies named in the complaint had conspired since 2008 to manipulate the prices of broiler chickens in violation of the Sherman Antitrust Act, 15 U.S.C. §§ 1-7 (the “Sherman Act”).

Other antitrust lawsuits quickly followed. On October 4, 2016, a group of individual consumers filed an antitrust class action complaint in U.S. District Court for the Northern District of Illinois (the “Monahan Complaint”) against Sanderson Farms and several of its industry peers, including Tyson, alleging violations of the Sherman Act.

Following the filing of the Monahan Complaint, Sanderson Farms’ share price fell $3.98, or 4.14%, to close at $92.21 on October 4, 2016.

On October 7, 2016, Pivotal Research downgraded Tyson from “Hold” to “Sell.” Explaining the downgrade, analyst Timothy Ramey directed investors’ attention to the “powerfully convincing” allegations of price manipulation by Sanderson Farms, Tyson, and their industry peers.

On news of the downgrade by Pivotal Research, Sanderson Farms’ share price fell $4.03, or 4.32%, to close at $89.15 on October 7, 2016.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

SOURCE: Pomerantz LLP


Go to Source

Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline – ENDP

NEW YORK, Nov. 18, 2016 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Endo International plc (“Endo” or the “Company”) (NASDAQ: ENDP) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-08645, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Endo securities between September 28, 2015 and November 2, 2016, both dates inclusive (the “Class Period”), seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Endo securities during the Class Period, you have until January 6, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

Endo develops, manufactures, and distributes pharmaceutical products and devices worldwide. The Company’s U.S. Generic Pharmaceuticals segment provides tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics, and transdermal patches for pain management, urology, central nervous system disorders, immunosuppression, oncology, women’s health, and cardiovascular disease markets. Endo sells its branded pharmaceuticals and generics directly, as well as through wholesale drug distributors.

On September 28, 2015, Endo announced that it had completed its $8.05 billion acquisition of Par Pharmaceutical Holdings, Inc. (“Par Pharmaceutical”) from the private investment firm TPG.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Endo’s subsidiary, Par Pharmaceutical, had colluded with several of its industry peers to fix generic drug prices; (ii) the foregoing conduct constituted a violation of federal antitrust laws; (iii) consequently, Endo’s revenues during the Class Period were in part the result of illegal conduct; and (iv) as a result of the foregoing, Endo’s public statements were materially false and misleading at all relevant times.

On November 3, 2016, media outlets reported that U.S. prosecutors were considering filing criminal charges by the end of 2016 against Par Pharmaceutical and several other pharmaceutical companies for unlawfully colluding to fix generic drug prices.

On this news, Endo’s share price fell $3.54, or 19.48%, to close at $14.63 on November 3, 2016.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert–pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-endo-international-plc-of-class-action-lawsuit-and-upcoming-deadline–endp-300366158.html

SOURCE Pomerantz LLP


Go to Source

Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Pattern Energy Group, Inc. of Class Action Lawsuit and Upcoming Deadline – PEGI

NEW YORK, Nov. 18, 2016 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Pattern Energy Group, Inc. (“Pattern” or the “Company”) (NASDAQ: PEGI) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 16-cv-06560, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Pattern securities between May 9, 2016 and November 4, 2016, both dates inclusive (the “Class Period”), seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Pattern securities during the Class Period, you have until January 10, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

Pattern operates as an independent power company that owns and operates power projects in the United States, Canada, and Chile. As of October 18, 2016, the Company had a portfolio of 18 wind power projects with a total owned capacity of 2,644 MW. Pattern sells electricity and renewable energy credits primarily to local utilities and local liquid independent system organizations markets.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Pattern’s operations were deficient with respect to various transaction, process level, and monitoring controls; (ii) as a result, Pattern lacked effective internal financial controls; and (iii) as a result of the foregoing, Pattern’s public statements were materially false and misleading at all relevant times.

On November 7, 2016, Pattern announced its financial and operating results for the quarter ended September 30, 2016 and disclosed a material weakness in internal controls over financial reporting. Pattern stated that its internal controls were “not effective as of September 30, 2016, due to the aggregation of internal control deficiencies related to the implementation, design, maintenance and operating effectiveness of various transaction, process level, and monitoring controls.”

On this news, Pattern’s share price fell $0.76, or 3.52%, to close at $20.86 on November 7, 2016.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert–pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-pattern-energy-group-inc-of-class-action-lawsuit-and-upcoming-deadline–pegi-300366157.html

SOURCE Pomerantz LLP


Go to Source

Hardison & Cochran Recognized on 2017 Best Law Firms List

North Carolina law firm listed in the field of Workers Compensation for Raleigh area

RALEIGH, NC, November 15, 2016 /24-7PressRelease/ — For the third year in a row, Hardison & Cochran, Attorneys at Law has been named to the Best Law Firms list in the annual rankings compiled by U.S. News and Best Lawyers.

Hardison & Cochran is listed on the Best Law Firms’ list in the field of Workers’ Compensation–claimants for the Raleigh metropolitan area.

The firms included on the 2017 Best Law Firms list are recognized for professional excellence, breadth of legal knowledge and consistently impressive reviews from clients and legal peers. The rankings are based on a rigorous evaluation that includes the collection of client and lawyer evaluations, reviews from leading attorneys in the practice area, and information provided by the firm as part of the submission process.

Among the criteria to be named to the Best Law Firms list, a firm must have at least one lawyer included in the latest edition of The Best Lawyers in America, which recognizes the top 4 percent of practicing attorneys in the United States. Firms are eligible for listing in the categories in which they have attorneys named.

Benjamin T. Cochran, managing partner of Hardison & Cochran, was recently listed in The Best Lawyers in America 2017 in the “Workers’ Compensation – Claimants” practice area. Mr. Cochran is a Board Certified Specialist in North Carolina Workers’ Compensation Law and has been recognized by Best Lawyers each year since 2014.

Hardison & Cochran represents workers who have been injured on the job, disabled people seeking Social Security Disability Insurance benefits and victims of personal injury accidents in Raleigh and throughout North Carolina. The law firm focuses on helping the people of North Carolina, not big corporations or insurance companies.

About Hardison & Cochran, Attorneys at Law

Hardison & Cochran, Attorneys at Law is a highly respected North Carolina personal injury, workers’ compensation, Social Security Disability law firm with offices in Raleigh, Durham, Fayetteville, Dunn, Greensboro, Southern Pines and Wilmington. The firm’s practice areas include workplace accidents, car accidents, truck accidents, motorcycle accidents, boating accidents, dog bites, dangerous drugs, defective medical devices, and nursing home abuse and negligence. For more information, call the firm toll-free at (800) 434-8399 or use the firm’s online contact form.

This article was originally distributed via 24-7 Press Release Newswire. 24-7 Press Release Newswire, Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com

For the original version on 24-7 Press Release Newswire visit: http://www.24-7pressrelease.com/press-release/hardison-amp-cochran-recognized-on-2017-best-law-firms-list-430908.php

Go to Source

UK passes the ‘most extreme surveillance law ever passed in a democracy’

Nov 17, 2016 – 05:15 PM UTC — AAPL: 109.95 (-0.04, -0.04%) | NASDAQ: 5333.97 (+39.39, +0.74%)

“The UK has just passed a massive expansion in surveillance powers, which critics have called ‘terrifying’ and ‘dangerous,’” Zack Whittaker reports for ZDNet. “The new law, dubbed the “snoopers’ charter”, was introduced by then-home secretary Theresa May in 2012, and took two attempts to get passed into law following breakdowns in the previous coalition government.”

“Four years and a general election later — May is now prime minister — the bill was finalized and passed on Wednesday by both parliamentary houses,” Whittaker reports. “But civil liberties groups have long criticized the bill, with some arguing that the law will let the UK government ‘document everything we do online.’”

“It’s no wonder, because it basically does,” Whittaker reports. “The law will force internet providers to record every internet customer’s top-level web history in real-time for up to a year, which can be accessed by numerous government departments; force companies to decrypt data on demand — though the government has never been that clear on exactly how it forces foreign firms to do that that; and even disclose any new security features in products before they launch. Not only that, the law also gives the intelligence agencies the power to hack into computers and devices of citizens (known as equipment interference), although some protected professions — such as journalists and medical staff — are layered with marginally better protections.”

Read more in the full article here.

MacDailyNews Take: Fools.

Look like Airstrip One was already too far gone. It’s not enough that every Brit alive has at least one government camera shoved up their ass 24/7/365?

Those who would give up essential liberty to purchase a little temporary safety deserve neither liberty nor safety. – Benjamin Franklin

SEE ALSO:
Apple teams up with other tech firms attack UK government’s Investigatory Powers Bill – March 26, 2016
UK’s Orwellian ‘Investigatory Powers Bill’ seeks to track every Brit’s online activity – February 9, 2016
Apple makes a strong case for strong encryption; some politicians don’t know what they’re talking about – December 22, 2015
Wikipedia founder: Apple should stop selling iPhones in the UK if ‘stupid’ new law banning Apple encryption is enacted – November 4, 2015
UK Prime Minister Cameron backs law to make Apple’s iPhone encryption illegal – November 3, 2015

Go to Source

Anderson Lloyd success at New Zealand Law Awards

November 18 2016

Anderson Lloyd success at New
Zealand Law Awards

Anderson Lloyd is celebrating
a third consecutive win as Best Mid-Sized Law Firm of The
Year, following last night’s New Zealand Law Awards in
Auckland.

Anderson Lloyd also won the prestigious Employer
of Choice Award, for firms with more than 100 staff.

“This
important recognition is a reflection of the efforts of all
our partners and staff,” says Anderson Lloyd chairman of
partners, Frazer Barton.

“The awards recognise our
contribution as a leading New Zealand law firm. This year we
have embarked on a new strategic direction which includes a
commitment to innovation, sustainability and community. We
are pleased to see this recognised in receiving both of
these awards.

“We were also delighted to have been
nominated in Deal Team of the Year (more than 100
Employees), International Deal of the Year, M&A Deal of the
Year and Mid-Market Deal of the Year.

“With offices in
Auckland, Christchurch, Dunedin and Queenstown we are
providing a seamless legal service to New Zealand and
overseas clients and this is reflected in our
success.

“The Employer of Choice Award reflects our strong
culture and our commitment to developing and supporting
staff. It is wonderful to see these efforts
recognised.”
Ends

© Scoop Media

Go to Source

PR sector seeks law to regulate operations

Nation Media Group CEO Joe Muganda addresses the 2016 Public Relations Society of Kenya (PRSK) Summit at the Whitesands Beach Resort in Mombasa on November 17, 2016. PHOTO | KEVIN ODIT 

The Public Relations Society of Kenya (PRSK) is fine tuning a Bill to be presented in Parliament in readiness for establishment of a law to regulate the sector.


Related Stories

The society is currently reviewing the Public Relations and Communications Bill, which will see establishment of an Act of Parliament to guide operations of PR practitioners.


Speaking during this year’s annual Summit at the Whitesands Beach Resort on Wednesday, PSRK chairperson Jane Gitau said with the growth of the public relations sector, there was need to set standards and regulations to instil professionalism.


They expect that the Bill will be presented in Parliament for debate early next year. Once in place, the Act will also see establishment of the Kenya Institute of Public Relations where PR practitioners will be trained.


“We would like to clean up our industry so that we hold one another accountable and get certified to work as PR practitioners. This will ensure there is ethics and accountability in the profession and that there is a way of skills and relationship building,” she said.


“It is necessary that we move towards regulation through an Act of Parliament. We also hope to set up an institute with the relevant curriculum that will train and certify public relations officers,” Ms Gitau said, adding that they had already held talks with the ICT ministry and relevant committees of the National Assembly.


She noted that whatever is being taught even in institutions of higher learning was not relevant to the practice of PR in the country, a situation the institute will seek to correct.


The Summit, which ends on Friday, is sponsored by the Nation Media Group, Kenya Ports Authority (KPA) and Kenya Civil Aviation Authority (KCAA).


Despite the growth of the PR sector in the country, many organisations have not taken it seriously, despite the important role it plays in maintaining the reputation of those institutions, the Summit heard.


Nation Media Group CEO Joe Muganda said the reputation of a company is key to the growth of the organisation and should be given the attention it deserves.


“The reputation of a company is priceless since it has been built over a period of time and it is paramount in ensuring that the organisation is alive. The mistake that some firms make is that they take their PR seriously only when there is a crisis,” he said.


“Reputation should be managed when everything is peaceful. If you are used to breaking promises don’t expect people to understand at the time of crisis,” Mr Muganda said.


Go to Source